National and Kapodistrian University of Athens
Δερεύνηση του ανοσοβιοχημικού προφίλ ασθενών με έκπτωση των γνωσιακών λειτουργιών και συσχέτιση με τα νευροψυχιατρικά συμπτώματα
Abstract
dc:descriptionBackground: Dementia and especially Alzheimer disease is a disease of the elderly,with a growing prevalence and high individual, social and economic burden. The careof vulnerable population has become a priority and investigations focus on findingmethods for more accurate diagnosis and more effective treatments. Of the existingevidence, it appears that inflammation plays a central role in the pathogenesis of thedisease and it would be valuable to detect specific factors of inflammation inperipheral blood, as markers of disease diagnosis and monitoring.METHODS: A total of 128 people were studied, 105 patients with Alzheimer'sdisease and 23 healthy controls. Patients were divided initially into two groups, basedon the receipt ([A]) or not ([NA]) acetylcholinesterase inhibitor (AChEI) andcompared among themselves and with the group of controls. Six months after startingtreatment with AChEI, a subgroup of [NA] has been re-assessed clinically and newblood measurements have been performed. Five years later there was a re-assessmentabout the disease severity in all patients. The clinical examination includedsomatometric measurements (BMI, waist circumference, hip circumference),heartbeat and arterial pressure in sitting and standing position. Psychometric scaleswere used for the assessment of cognition (Mini Mental State Examination, MMSE),functionality (Alzheimer's Disease Cooperative Study-Activities of Daily Living,ADCS-ADL), the stage of the disease (Clinical Dementia Rating, CDR, Global ScaleDeterioration, GDS) and to detect depressive (Cornell Scale for Depression inDementia, CSDD) and neuropsychiatric symptoms (Neuropsychiatric Inventory,NPI). Based on the latest literature, proinflammatory cytokines (IFNγ, IL-6, IL-1β,TNFα), lipidemic factors (ApoA-I, Lp(α), anti-oxLDL), adhesion molecules (VCAM- 1, ICAM-1) and CRP were studied. For the measurements of cytokines, an enzymelinkedimmunosorbent assay (Enzyme-Linked-Immuno-SPOT, ELISPOT) wasselected, which detects the production of cytokines by peripheral monocytes bloodcells. It is considered more sensitive and accurate method for the determination ofcytokines in comparison with ELISA method, which is used in most previous studies.The rest of biochemical factors were measured in plasma of participants with ELISA.Results: The secretion of cytokines differed in statistically significant extent, bothbetween patients and controls, as also before and after the admission of AChEI. Thereduction in the secretion of IFNγ and TNFα was associated with improvement of depressive symptoms, while the decrease of IL-6 was associated with improvement inneuropsychiatric symptoms. Also, apoA-I levels were decreased after treatment withAChEI. Anti-oxLDL levels were correlated positively with the scales MMSE andADCS, while levels of sICAM-1 were correlated positively with the duration of thedisease. The levels of Lp(a) and sVCAM-1 associated with disease severity. CRP hasnot been associated with any of disease parameter. Receiving antipsychotic therapywas associated with a worse prognosis, while the severity of the disease and theoccurrence of neuropsychiatric symptoms associated with increased mortality.Conclusion: The observed significant difference on the secretion of cytokinesbetween patients and controls indicates that inflammation is present in AD and iseventually involved in pathogenesis of the disease. After the administration of therapywith acetylcholinesterase inhibitor for six months period, secretion of cytokinesdeclined, without however reaching the levels of healthy controls. The observedcorrelation between the reduction of depressive and neuropsychiatric symptoms andthe reduction of cytokine secretion is very important and raises the need for furtherinvestigation about the actual role of cytokines in both AD and depression.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Stamouli, Evangelia
- Σταμούλη, Ευαγγελία
Subjects
dc:subject × 16- Νόσος Αlzheimer
- Προφλεγμονώδης ωτοκίνες
- Ανοσοενζυμική μέθοδος ELISPOT
- Αναστολείς ακετυλοχολινεστεράσης
- Κατάθλιψη στη NA
- Αlzheimer disease
- Pro-inflammatory cytokines
- ELISPOT assay
- Acetylcholinesterase Inhibitors
- Depression in AD
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Βασική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/41008